Created with LunacyBack to Overview

Dr. Digvijay Porwal

N° 91

Date finished: Sept. 2018

Batch: WS14

Country of origin: India

Supervisor(s): Prof. Oestreich (TU), Prof. Driess (TU)

Area PhD: B(C6F5)3-catalysed reduction reactions

 

Present occupation:
08/2024 - now: Principal Scientist, API Pharma MS&T at Bristol Myers Squibb1, Dublin, Ireland

Current Role and Tasks: My responsibility is to ensure new and approved drugs supply worldwide is maintained, that encompass, API and DP manufacturing at External manufacturing Sites (Asia, EU, USA). Primary task is to find right external partners for commercial drug manufacturing, ensure R&D protocols for Drug manufacturing are scalable, robust and cost effective. The work is heavily cross-functional team driven, closely working with R&D, Operation, Quality, Supply chain, Finance, worldwide vendors and Regulatory Bodies (FDA/EMEA/HPRA).
Level of Team Responsibility: Individual contributors with 16 direct reports including senior scientists and team leaders.
Industry Sector:  Pharmaceutical (Small Molecules and Biologics)

Past occupations:
01/2022 - 07/2024: Process Scientist - New Product Introduction (NPI) at AbbVie, Irland
12/2019 - 09/2021: Senior Scientist, Team Leader at Ryvu Therapeutics, Poznan, Poland
10/2018 - 12/2019: Scientist, Drug Discovery Department, Selvita S.A., Poznan, Poland
12/2017 - 09/2018: Organic Synthesis Specialist II, Contract Chemistry Research, Selvita S.A., Krakow, Poland

LinkedIn

1 Fortune 500, Top 10 Pharmaceutical in the world with approx. 64.000 employees, revenue 68 Billion$, founded 1887